CD1C and glioblastoma: In contrast, oncolysates of both glioblastoma and BXPC3-treated cell lines did not induce significant differences in the expression levels of maturation markers in BDCA-1+/BDCA-3+ cDCs as an effect of oHSV1-FLT3L-induced oncolysates.